Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Keratosis, Actinic × Triamcinolone × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Dermatologic 1

Conditions

Precancerous Conditions 1 Keratosis, Actinic 1 Carcinoma, Basal Cell 1

Interventions

Aminolevulinic Acid 4 tirbanibulin 1 perillyl alcohol 1 Triamcinolone 1 Microarray Analysis 1 Laser Therapy 1 Imiquimod 1 Excipients 1 Eflornithine 1 Deoxyribonuclease (Pyrimidine Dimer) 1 Celecoxib 1 Biopsy 1 BF-200 ALA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed

DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡